Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
7.75
0.00 (0.00%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Spruce Biosciences Stock Forecast
SPRB's stock price has decreased by -75.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Spruce Biosciences stock ranges from a low of $37.5 to a high of $225. The average analyst price target of $131.25 forecasts a 1,593.55% increase in the stock price over the next year.
Price Target: $131.25 (+1,593.55%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
The average analyst rating for Spruce Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $113 → $38 | Hold | Maintains | $113 → $38 | +383.87% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 16, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 12, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades $225 | Buy → Hold | Downgrades | $225 | +2,803.23% | Dec 11, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $150 → $113 | Hold | Reiterates | $150 → $113 | +1,351.61% | Dec 11, 2024 |
Financial Forecast
Revenue This Year
1.02M
from 4.91M
Decreased by -79.23%
Revenue Next Year
n/a
from 1.02M
EPS This Year
-65.03
from -96.39
EPS Next Year
-11.54
from -65.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.1M | n/a | |
| Avg | 1.0M | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -57.2% | - | |
| Avg | -79.2% | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -53.55 | -11.88 | |
| Avg | -65.03 | -11.54 | |
| Low | -74.97 | -11.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.